Corpus Intelligence IC Memo — KINDRED HOSPITAL SUGAR LAND 2026-04-26 08:06 UTC
IC Memo — KINDRED HOSPITAL SUGAR LAND
Investment Committee Memorandum | TX | 80 beds | Grade D | EBITDA uplift $2.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KINDRED HOSPITAL SUGAR LAND

CCN 452080 | FORT BEND, TX | 80 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

KINDRED HOSPITAL SUGAR LAND is a 80-bed community hospital in FORT BEND, TX with $36.4M in net patient revenue and a 3.0% operating margin. The hospital serves a payer mix of 44.1% Medicare, 0.0% Medicaid, and 55.9% commercial.

Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.0% to 10.3% (+736bps).

Net Revenue HCRIS$36.4M
Current EBITDA COMPUTED$1.1M
Operating Margin COMPUTED3.0%
Occupancy HCRIS48.4%
Revenue / Bed COMPUTED$454K
Net-to-Gross HCRIS13.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
223
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 3.0% places it above the state median. Among 223 size-comparable peers (40-160 beds), the median margin is 1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 223 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KINDRED HOSPITAL SUGAR LAND (Target)TX80$36.4M3.0%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
BAYLOR SW MEDICAL CENTER- WAXATX123$273.6M15.9%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
BAYLOR S&W MEDICAL CENTER - PLTX160$242.5M4.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$763K+210bp18mo
Cost to Collect4.5%2.5%$727K+200bp12mo
Denial Rate Reduction12.0%6.5%$720K+198bp12mo
A/R Days Reduction5200.0%3800.0%$442K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$763K
Cost to Collect
$727K
Denial Rate Reduction
$720K
A/R Days Reduction
$442K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.7M
Current EBITDA$1.1M
+ RCM Uplift+$2.7M
Pro Forma EBITDA$3.8M
Current Margin3.0%
Pro Forma Margin10.3%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.7M$33.9M20.38x82.8%
Base (11x exit)10.0x11.0x$1.7M$37.8M22.75x86.8%
Bull Case9.0x11.0x$1.5M$47.2M31.54x99.4%
Bull (12x exit)9.0x12.0x$1.5M$51.9M34.70x103.3%
Bear Case11.0x10.0x$1.8M$20.0M10.92x61.3%
Bear (11x exit)11.0x11.0x$1.8M$22.6M12.34x65.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 223 hospitals with 40-160 beds
  • Same-state prioritization (n=224)
  • Comp margins: P25=-12.4% / P50=1.7% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.